Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Nina Martinez"'
Autor:
Jocelyn L. Bowden, David J. Hunter, Kathryn Mills, Kelli Allen, Kim Bennell, Andrew M. Briggs, K. Dziedzic, Rana S. Hinman, Jason S. Kim, Nina Martinez, Jonathan G. Quicke, Bryan Tan Yijia, Martin van der Esch, Josep Verges, Jillian Eyles
Publikováno v:
Osteoarthritis and Cartilage Open, Vol 5, Iss 4, Pp 100408- (2023)
Objective: The Joint Effort Initiative (JEI) is an international collaboration of clinicians, researchers, and consumer organisations with a shared vision of improving the implementation of osteoarthritis management programs (OAMPs). This study aimed
Externí odkaz:
https://doaj.org/article/f69e56b1d17b4cd28aa1c943e22b2764
Autor:
Ryan T. Merrell, MD, Kelly Claire Simon, ScD, Nina Martinez, MD, Rosa Maria Vazquez, BS, Bryce Hadsell, MS, Alexander Epshteyn, MPM, Gary Wilk, PhD, Roberta Frigerio, MD, Demetrius M. Maraganore, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 625-634 (2021)
Objective: To develop and implement a customized toolkit within the electronic medical record (EMR) to standardize care of patients with brain tumors. Patients and Methods: We built a customized structured clinical documentation support toolkit to ca
Externí odkaz:
https://doaj.org/article/23423058a0744f7e9af2dac25a9a7f54
Autor:
Ryan Miller, Andrew Song, Ayesha Ali, Muneeb Niazi, Voichita Bar-Ad, Nina Martinez, Jon Glass, Iyad Alnahhas, David Andrews, Kevin Judy, James Evans, Christopher Farrell, Maria Werner-Wasik, Inna Chervoneva, Michele Ly, Joshua Palmer, Haisong Liu, Wenyin Shi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionStandard-of-care treatment for patients with newly diagnosed glioblastoma (GBM) after surgery or biopsy includes concurrent chemoradiation followed by maintenance temozolomide (TMZ) with tumor treating fields (TTFields). Preclinical studi
Externí odkaz:
https://doaj.org/article/c807b96170d949a0be737e1861ec0f90
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 8, Pp 17157-17167 (2013)
Brain metastases are a much-feared complication of cancer. The development of brain metastases requires a malignant cell to acquire characteristics that facilitate dissemination away from the primary site, entrance into the nervous system, and establ
Externí odkaz:
https://doaj.org/article/626b80dc8ab1468c9864599956624249
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Craig Hooper, Kara Pigott, Mark A. Exley, Sami Sauma, Emily Bongiorno, Donald Y. Ye, Rhonda Kean, Mark Curtis, Mikhail Prosniak, Haisong Liu, Maria Werner-Wasik, Wenyin Shi, Nina Martinez, Lyndon Kim, Kofi-Buaku Atsina, Adam Flanders, Kiran Talekar, Lawrence Kenyon, Larry A. Harshyne, Samantha Garcia, Charles B. Scott, Kevin D. Judy, David W. Andrews
Purpose:Despite standard of care (SOC) established by Stupp, glioblastoma remains a uniformly poor prognosis. We evaluated IGV-001, which combines autologous glioblastoma tumor cells and an antisense oligonucleotide against IGF type 1 receptor (IMV-0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406698752ca96982d2f83b589afabdd9
https://doi.org/10.1158/1078-0432.c.6530508
https://doi.org/10.1158/1078-0432.c.6530508
Autor:
D. Craig Hooper, Kara Pigott, Mark A. Exley, Sami Sauma, Emily Bongiorno, Donald Y. Ye, Rhonda Kean, Mark Curtis, Mikhail Prosniak, Haisong Liu, Maria Werner-Wasik, Wenyin Shi, Nina Martinez, Lyndon Kim, Kofi-Buaku Atsina, Adam Flanders, Kiran Talekar, Lawrence Kenyon, Larry A. Harshyne, Samantha Garcia, Charles B. Scott, Kevin D. Judy, David W. Andrews
Determination of severity for adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d398eaf23e2653a136866730a4f138
https://doi.org/10.1158/1078-0432.22480692
https://doi.org/10.1158/1078-0432.22480692
Autor:
D. Craig Hooper, Kara Pigott, Mark A. Exley, Sami Sauma, Emily Bongiorno, Donald Y. Ye, Rhonda Kean, Mark Curtis, Mikhail Prosniak, Haisong Liu, Maria Werner-Wasik, Wenyin Shi, Nina Martinez, Lyndon Kim, Kofi-Buaku Atsina, Adam Flanders, Kiran Talekar, Lawrence Kenyon, Larry A. Harshyne, Samantha Garcia, Charles B. Scott, Kevin D. Judy, David W. Andrews
Pan-Cancer Immunity Panel for advanced analysis of T cell activation scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6204349e3f6d0cd9984d11ddacaaf0bb
https://doi.org/10.1158/1078-0432.22480695.v1
https://doi.org/10.1158/1078-0432.22480695.v1
Autor:
Demetrius M. Maraganore, Alexander Epshteyn, Gary Wilk, Nina Martinez, Bryce Hadsell, Kelly Claire Simon, Roberta Frigerio, Ryan Merrell, Rosa Maria Vazquez
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 625-634 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To develop and implement a customized toolkit within the electronic medical record (EMR) to standardize care of patients with brain tumors. Patients and Methods We built a customized structured clinical documentation support toolkit to capt
Autor:
Lisa Mayr, Maria Trissal, Kallen Schwark, Jenna Labelle, Andrew Groves, Julia Furtner-Srajer, Jeffrey Supko, Liesa Weiler-Wichtl, Olivia Hack, Jacob Rozowsky, Joana G. Marques, Eshini Pandatharatna, Ulrike Leiss, Verena Rosenmayr, Frank Dubois, Noah F. Greenwald, Sibylle Madlener, Armin S. Guntner, Hana Pálová, Natalia Stepien, Daniela Lötsch-Gojo, Christian Dorfer, Karin Dieckmann, Andreas Peyrl, Amedeo A. Azizi, Alicia Baumgartner, Ondřej Slabý, Petra Pokorná, Pratiti Bandopadhayay, Rameen Beroukhim, Keith Ligon, Christof Kramm, Annika Bronsema, Simon Bailey, Ana Guerreiro Stücklin, Sabine Mueller, David T. Jones, Natalie Jäger, Jaroslav Štěrba, Leonhard Müllauer, Christine Haberler, Chandan Kumar-Sinha, Arul Chinnaiyan, Rajen Mody, Mary Skrypek, Nina Martinez, Daniel C. Bowers, Carl Koschmann, Johannes Gojo, Mariella Filbin
Publikováno v:
Cancer Research. 83:5719-5719
PDGFRA has been shown to be commonly altered in high-grade gliomas (HGGs), including histone 3 lysine 27-mutated diffuse midline gliomas (H3K27M DMG), a disease with almost no long-term survivors. Here, we performed comprehensive genomic and transcri